Jubilant Pharmova
JUBLPHARMA.NS
$8.19
Share price
-0.44%
Change (1 day)
120.75%
Change (1 year)
Categories
Revenue for Jubilant Pharmova (JUBLPHARMA.NS)
Revenue in 2023 (TTM): $0.79 B
According to Jubilant Pharmova's latest financial reports the company's current revenue (TTM) is $0.79 B. In 2022 the company made a revenue of $0.76 B a decrease over the years 2021 revenue that were of $0.82 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Jubilant Pharmova from 2013 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.79 B | 4.18% |
| 2022 | $0.76 B | -7.36% |
| 2021 | $0.82 B | -8.81% |
| 2020 | $0.90 B | -23.42% |
| 2019 | $1.17 B | -8.46% |
| 2018 | $1.28 B | 22.88% |
| 2017 | $1.04 B | 22.3% |
| 2016 | $0.85 B | -3.15% |
| 2015 | $0.88 B | -6.89% |
| 2014 | $0.94 B | 1.59% |
| 2013 | $0.93 B |